Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04229017 · ClinicalTrials.gov registry record · NA

Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD

A NA study of Degenerative Disc Disease, sponsored by Providence Medical Technology.

Active
Registry status
NA
Development phase
236
Enrollment target
17
Study locations

NCT04229017: Active NA study of Degenerative Disc Disease, sponsored by Providence Medical Technology.

NCT04229017 is a NA study of Degenerative Disc Disease that is active but no longer recruiting, run by Providence Medical Technology. The registered enrollment target is 236 participants, above the 163-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (45% higher). The trial reports 17 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04229017, a NA study of Degenerative Disc Disease, is active but no longer recruiting, sponsored by Providence Medical Technology.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
236 participants
Enrollment target
17
Study locations

Study Summary

This study will evaluate the safety and effectiveness of a device called "Posterior Cervical Stabilization System or PCSS" when used along with posterior cervical fusion (PCF) in combination with anterior cervical discectomy and fusion (ACDF) in the treatment of multi-level cervical degenerative disease.

Primary Outcome

An individual subject is considered a fusion success if there is evidence of bridging trabecular bone across endplates and \< 2° total angular motion

Conditions Studied

Interventions

  • PROCEDURE Anterior Cervical Discectomy and Fusion
  • DEVICE Posterior Cervical Stabilization System (PCSS)

Study Locations (17)

Louisiana

  • Bone and Joint Clinic of Baton Rouge - Baton Rouge
  • LSU Health - New Orleans
  • Spine Institute of Louisiana - Shreveport

North Carolina

  • The University of North Carolina at Chapel Hill - Chapel Hill
  • Pinehurst Surgical Clinic - Pinehurst
  • Atlantic Neurosurgical & Spine Specialists - Wilmington

California

  • Scripps - Encinitas
  • OrthoNorCal - Los Gatos

Arizona

  • Barrow Neurological Institute - Phoenix

Colorado

  • Spine Colorado - Durango

Illinois

  • Rush University Medical Center - Chicago

Kentucky

  • The Orthopaedic Institute - Paducah

Maryland

  • LifeBridge Health - Sinai Hospital of Baltimore - Baltimore

Trial Details

FieldValue
Enrollment Target 236 participants
Start Date 2020-03-18
Est. Completion 2025-12
Phase NA
Providence Medical Technology

2 total trials

What the registry record for NCT04229017 still lists

NCT04229017 is an interventional study that assigns participants to a tested intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap, above the 163-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (45% higher).

The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 2 interventions - of which Anterior Cervical Discectomy and Fusion is the first listed.

NCT04229017 lists 17 locations in 12 states (Louisiana, North Carolina, California).

Frequently Asked Questions

What is clinical trial NCT04229017 about?

NCT04229017 is a clinical study titled "Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD". This study will evaluate the safety and effectiveness of a device called "Posterior Cervical Stabilization System or PCSS" when used along with posterior cervical fusion (PCF) in combination with anterior cervical discectomy and fusion (ACDF) in the treatment of multi-level cervical degenerative dis...

What is the current status of trial NCT04229017?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 236 participants. The study started on 2020-03-18. Estimated completion is 2025-12.

What conditions does trial NCT04229017 study?

This clinical trial studies the following conditions: Degenerative Disc Disease.

What interventions are being tested in trial NCT04229017?

The interventions under investigation include: Anterior Cervical Discectomy and Fusion (PROCEDURE), Posterior Cervical Stabilization System (PCSS) (DEVICE).

Who is sponsoring clinical trial NCT04229017?

This trial is sponsored by Providence Medical Technology, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04229017 being conducted?

This trial has 17 study locations across Arizona, California, Colorado, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04229017's enrollment target sits among peer trials

236 10th of 42 higher than 33 of 42 other Degenerative Disc Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04995341 · 236 participants · NA

    Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)

  • NCT05822362 · 236 participants · Phase 2

    CBD for Individuals at Risk for Alzheimer's Disease

  • NCT06200103 · 236 participants · Phase 2

    Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

  • NCT06494072 · 236 participants · Phase 4

    Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04229017, the US trial registry maintained by the National Library of Medicine. NCT04229017 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.